In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...
Utah is expected to join a national settlement with Purdue Pharma, makers of OxyContin, for the company's role in the U.S. opioid epidemic. For its part, the state could receive nearly $60 million.
They deny wrongdoing and stopped short of offering an apology for the impact of Purdue Pharma's involvement in the opioid market, centred around the promotion and marketing of its OxyContin ...
In a $7.4 billion multistate settlement with members of the Sackler family and their company, Purdue Pharma, Inc. for their role in creating and perpetuating the opioid crisis, Virginia is ...
A judge in the US has approved the sale of Purdue Pharma’s consumer health business ... opioid lawsuits centred around the promotion and marketing of its OxyContin (oxycodone) painkiller ...
A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.
Jan 13 (Reuters) - The Sackler family owners of Purdue Pharma are offering to increase ... addiction crisis in the U.S. through deceptive marketing of its pain medication, OxyContin.